Share this article
Share this article
TAIPEI, Jan. 12, 2021 /PRNewswire/ Winnoz, a biotech company based in Taipei, focuses on innovations enabling healthcare resources accessible for anyone and anywhere. With the POCT platform from blood collection, detection and big data analysis, Winnoz enables more contribution to human health management for anyone, anywhere, especially under the attack and threat of the pandemic. We believe that the COVID-19 screening and vaccination efficacy test would play a more important role as vaccines roll out to bring our life back to normal. said Dr. Joses Hsiung, Winnoz Founder and CEO. The advent of new technologies and innovations because of the challenges of the ongoing pandemic will push the global healthcare ecosystem to new boundaries. For example, how to deploy and roll out the screening, vaccines and vaccine efficacy testing quickly would be very crucial. eGGi, a rapid and on-site isothermal PCR, is able to support screening for anyon